University of Tasmania
Browse

File(s) under permanent embargo

Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis

journal contribution
posted on 2023-05-18, 13:57 authored by Liesel FitzgeraldLiesel Fitzgerald, Karlins, E, Karyadi, DM, Kwon, EM, Koopmeiners, JS, Stanford, JL, Ostrander, EA
The fibroblast growth factor receptor 4 (FGFR4) is thought to be involved in many critical cellular processes and has been associated with prostate cancer risk. Four single nucleotide polymorphisms (SNPs) within or near FGFR4 were analyzed in a population-based study of 1458 prostate cancer patients and 1352 age-matched controls. We found no evidence to suggest that any of the FGFR4 SNP genotypes were associated with prostate cancer risk or with disease aggressiveness, Gleason score or stage. A weak association was seen between rs351855 and prostate cancer-specific mortality. Subset analysis of cases that had undergone radical prostatectomy revealed an association between rs351855 and prostate cancer risk. Although our results confirm an association between FGFR4 and prostate cancer risk in radical prostatectomy cases, they suggest that the role of FGFR4 in disease risk and outcomes at a population-based level appears to be minor.

History

Publication title

Prostate Cancer and Prostatic Diseases

Volume

12

Pagination

192-7

ISSN

1365-7852

Department/School

Menzies Institute for Medical Research

Publisher

Nature Publishing Group

Place of publication

United Kingdom

Rights statement

Copyright 2009 Nature Publishing Group All rights reserved

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC